MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/s0140-6736(15)61140-0

Медицинская библиотека · Lancet (London, England) · 2015

Feasibility and effectiveness of oral cholera vaccine in an urban endemic setting in Bangladesh: a cluster randomised open-label trial.

Qadri Firdausi, Ali Mohammad, Chowdhury Fahima, Khan Ashraful Islam, Saha Amit, Khan Iqbal Ansary, Begum Yasmin A, Bhuiyan Taufiqur R, Chowdhury Mohiul Islam, Uddin Md Jasim, Khan Jahangir A M, Chowdhury Atique Iqbal, Rahman Anisur, Siddique Shah Alam, Asaduzzaman Muhammad, Akter Afroza, Khan Arifuzzaman, Ae You Young, Siddik Ashraf Uddin, Saha Nirod Chandra, Kabir Alamgir, Riaz Baizid Khoorshid, Biswas Shwapon Kumar, Begum Farzana, Unicomb Leanne, Luby Stephen P, Cravioto Alejandro, Clemens John D

СтатьяРандомизированное исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Cholera is endemic in Bangladesh with epidemics occurring each year. The decision to use a cheap oral killed whole-cell cholera vaccine to control the disease depends on the feasibility and effectiveness of vaccination when delivered in a public health setting. We therefore assessed the feasibility and protective effect of delivering such a vaccine through routine government services in urban Bangladesh and evaluated the benefit of adding behavioural interventions to encourage safe drinking water and hand washing to vaccination in this setting.

METHODS

We did this cluster-randomised open-label trial in Dhaka, Bangladesh. We randomly assigned 90 clusters (1:1:1) to vaccination only, vaccination and behavioural change, or no intervention. The primary outcome was overall protective effectiveness, assessed as the risk of severely dehydrating cholera during 2 years after vaccination for all individuals present at time of the second dose. This study is registered with ClinicalTrials.gov, number NCT01339845.

FINDINGS: Of 268,896 people present at baseline, we analysed 267,270: 94,675 assigned to vaccination only, 92,539 assigned to vaccination and behavioural change, and 80,056 assigned to non-intervention. Vaccine coverage was 65% in the vaccination only group and 66% in the vaccination and behavioural change group. Overall protective effectiveness was 37% (95% CI lower bound 18%; p=0·002) in the vaccination group and 45% (95% CI lower bound 24%; p=0·001) in the vaccination and behavioural change group. We recorded no vaccine-related serious adverse events.

INTERPRETATION: Our findings provide the first indication of the effect of delivering an oral killed whole-cell cholera vaccine to poor urban populations with endemic cholera using routine government services and will help policy makers to formulate vaccination strategies to reduce the burden of severely dehydrating cholera in such populations.

FUNDING: Bill & Melinda Gates Foundation.

Для цитирования: Qadri Firdausi, Ali Mohammad, Chowdhury Fahima, Khan Ashraful Islam, Saha Amit, Khan Iqbal Ansary, Begum Yasmin A, Bhuiyan Taufiqur R, Chowdhury Mohiul Islam, Uddin Md Jasim, Khan Jahangir A M, Chowdhury Atique Iqbal, Rahman Anisur, Siddique Shah Alam, Asaduzzaman Muhammad, Akter Afroza, Khan Arifuzzaman, Ae You Young, Siddik Ashraf Uddin, Saha Nirod Chandra, Kabir Alamgir, Riaz Baizid Khoorshid, Biswas Shwapon Kumar, Begum Farzana, Unicomb Leanne, Luby Stephen P, Cravioto Alejandro, Clemens John D. Feasibility and effectiveness of oral cholera vaccine in an urban endemic setting in Bangladesh: a cluster randomised open-label trial.. Lancet (London, England). 2015. DOI: 10.1016/s0140-6736(15)61140-0.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.